Felix Baker

Affiliations

  • Director at Neoleukin Therapeutics Inc. (NLTX), 2022-05-16
  • Large Shareholder, Director at Tscan Therapeutics Inc. (TCRX), 2022-05-12
  • Large Shareholder, Director at Igm Biosciences Inc. (IGMS), 2022-04-05
  • Large Shareholder, Director at Incyte Corp (INCY), 2022-04-04
  • Large Shareholder, Director at Seagen Inc. (SGEN), 2022-03-10
  • Large Shareholder, Director at Kodiak Sciences Inc. (KOD), 2022-02-17
  • Large Shareholder at Entrada Therapeutics Inc. (TRDA), 2021-12-16
  • Large Shareholder, Director at Talis Biomedical Corp (TLIS), 2021-11-19
  • Large Shareholder, Director at Acadia Pharmaceuticals Inc (ACAD), 2021-06-24
  • Large Shareholder, Director at Prelude Therapeutics Inc (PRLD), 2021-06-22
  • Large Shareholder, Director at Beigene Ltd. (BGNE), 2021-06-21
  • Director at Aeglea Biotherapeutics Inc. (AGLE), 2021-06-10
  • Large Shareholder, Director at Dbv Technologies S.a. (DBVT), 2021-01-12
  • Director at Kiniksa Pharmaceuticals Ltd. (KNSA), 2020-07-28
  • Large Shareholder at Atreca Inc. (BCEL), 2020-07-20
  • Director at Alexion Pharmaceuticals Inc. (ALXN), 2020-05-18
  • Director at Zymeworks Inc. (ZYME), 2020-05-12
  • Large Shareholder, Director at Genomic Health Inc (GHDX), 2019-10-03
  • Large Shareholder at Idera Pharmaceuticals Inc. (IDRA), 2019-07-03
  • Other at Hookipa Pharma Inc. (HOOK), 2019-04-23
  • Large Shareholder at Principia Biopharma Inc. (PRNB), 2018-09-13
  • Large Shareholder at Invitae Corp (NVTA), 2018-03-29
  • Large Shareholder at Bellicum Pharmaceuticals Inc (BLCM), 2018-01-19
  • Other at Mirati Therapeutics Inc. (MRTX), 2017-11-20
  • Other at Rhythm Pharmaceuticals Inc. (RYTM), 2017-10-06
  • Large Shareholder at Biocryst Pharmaceuticals Inc (BCRX), 2016-08-16
  • Other at Intellia Therapeutics Inc. (NTLA), 2016-05-11
  • Other at Xoma Corp (XOMA), 2015-07-23
  • Other at Synageva Biopharma Corp (GEVA), 2015-06-23
  • Large Shareholder, Director at Ardea Biosciences Inc. (RDEA), 2012-06-21
  • Large Shareholder at Tranzyme Inc (TZYM), 2012-03-14
  • Large Shareholder at Pharmacyclics Inc (PCYC), 2012-02-14
  • Large Shareholder at Diadexus Inc. (DDXS), 2012-02-01
  • Large Shareholder at Adolor Corp (ADLR), 2012-01-03
  • Large Shareholder at Viropharma Inc (VPHM), 2011-12-16
  • Large Shareholder at Auxilium Pharmaceuticals Inc (AUXL), 2011-08-03
  • Large Shareholder at Ap Pharma Inc (APPA), 2011-07-06
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
SGEN $59.46 294,178 Large Shareholder, Director 40,885,092 2016-11-08 Filing
SGEN $59.46 32,122 Large Shareholder, Director 4,874,864 2016-11-08 Filing
SGEN $58.74 50,667 Large Shareholder, Director 40,590,914 2016-11-07 Filing
SGEN $58.74 5,533 Large Shareholder, Director 4,842,742 2016-11-07 Filing
SGEN $55.99 18,616 Large Shareholder, Director 40,540,247 2016-11-03 Filing